,address1,city,state,zip,country,phone,website,industry,sector,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,sharesShort,sharesShortPriorMonth,sharesShortPreviousMonthDate,dateShortInterest,sharesPercentSharesOut,heldPercentInsiders,heldPercentInstitutions,shortRatio,shortPercentOfFloat,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,recommendationMean,recommendationKey,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,380 Lackawanna Place,South Orange,NJ,07079,United States,201-343-5202,https://www.nephros.com,Medical Instruments & Supplies,Healthcare,"Nephros, Inc. engages in development and sale of high performance water solutions to the medical and commercial markets in the United States. The company operates in two segments: Water Filtration and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it manufactures and sells water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and Nanoguard brands for the food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.",27,"{'maxAge': 1, 'name': 'Mr. Andrew  Astor', 'age': 65, 'title': 'Interim CFO & Advisor', 'yearBorn': 1957, 'fiscalYear': 2022, 'totalPay': 334750, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,1.45,1.42,1.42,1.49,1.45,1.42,1.42,1.49,0.0,1.165283,-35.5,3358,3358,7296,5770,5770,1.4,1.54,900,3200,15063786,0.91,2.5,1.2339274,1.491,1.3361,0.0,0.0,USD,11685603,-0.40039003,5655153,10484900,37420,23763,1690761600,1693440000,0.0036000002,0.11525,0.40390998,4.48,0.0057,0.825,1.7212121,1672444800,1703980800,1688083200,-2855000,-0.26,-0.04,1:9,1562716800,0.957,-4.764,NCM,EQUITY,NEPH,NEPH,"Nephros, Inc.","Nephros, Inc.",1095773400,America/New_York,EDT,-14400000,1.42,2.5,buy,4060000,0.387,-2453000,857000,4.708,6.612,12208000,9.902,1.184,-0.13393,-0.25625,4731000,1873125,137000,0.244,0.53023,-0.20093,-0.2224,USD,
1,380 Lackawanna Place,South Orange,NJ,07079,United States,201-343-5202,https://www.nephros.com,Medical Instruments & Supplies,Healthcare,"Nephros, Inc. engages in development and sale of high performance water solutions to the medical and commercial markets in the United States. The company operates in two segments: Water Filtration and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it manufactures and sells water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and Nanoguard brands for the food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.",27,"{'maxAge': 1, 'name': 'Mr. Robert  Banks', 'title': 'Pres, CEO & Director', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,1.45,1.42,1.42,1.49,1.45,1.42,1.42,1.49,0.0,1.165283,-35.5,3358,3358,7296,5770,5770,1.4,1.54,900,3200,15063786,0.91,2.5,1.2339274,1.491,1.3361,0.0,0.0,USD,11685603,-0.40039003,5655153,10484900,37420,23763,1690761600,1693440000,0.0036000002,0.11525,0.40390998,4.48,0.0057,0.825,1.7212121,1672444800,1703980800,1688083200,-2855000,-0.26,-0.04,1:9,1562716800,0.957,-4.764,NCM,EQUITY,NEPH,NEPH,"Nephros, Inc.","Nephros, Inc.",1095773400,America/New_York,EDT,-14400000,1.42,2.5,buy,4060000,0.387,-2453000,857000,4.708,6.612,12208000,9.902,1.184,-0.13393,-0.25625,4731000,1873125,137000,0.244,0.53023,-0.20093,-0.2224,USD,
2,380 Lackawanna Place,South Orange,NJ,07079,United States,201-343-5202,https://www.nephros.com,Medical Instruments & Supplies,Healthcare,"Nephros, Inc. engages in development and sale of high performance water solutions to the medical and commercial markets in the United States. The company operates in two segments: Water Filtration and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it manufactures and sells water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and Nanoguard brands for the food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.",27,"{'maxAge': 1, 'name': 'Brianne  McGuire', 'title': 'Director of Brand & Marketing', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,1.45,1.42,1.42,1.49,1.45,1.42,1.42,1.49,0.0,1.165283,-35.5,3358,3358,7296,5770,5770,1.4,1.54,900,3200,15063786,0.91,2.5,1.2339274,1.491,1.3361,0.0,0.0,USD,11685603,-0.40039003,5655153,10484900,37420,23763,1690761600,1693440000,0.0036000002,0.11525,0.40390998,4.48,0.0057,0.825,1.7212121,1672444800,1703980800,1688083200,-2855000,-0.26,-0.04,1:9,1562716800,0.957,-4.764,NCM,EQUITY,NEPH,NEPH,"Nephros, Inc.","Nephros, Inc.",1095773400,America/New_York,EDT,-14400000,1.42,2.5,buy,4060000,0.387,-2453000,857000,4.708,6.612,12208000,9.902,1.184,-0.13393,-0.25625,4731000,1873125,137000,0.244,0.53023,-0.20093,-0.2224,USD,
3,380 Lackawanna Place,South Orange,NJ,07079,United States,201-343-5202,https://www.nephros.com,Medical Instruments & Supplies,Healthcare,"Nephros, Inc. engages in development and sale of high performance water solutions to the medical and commercial markets in the United States. The company operates in two segments: Water Filtration and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it manufactures and sells water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and Nanoguard brands for the food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.",27,"{'maxAge': 1, 'name': 'Vashone R. Thomas', 'title': 'VP of Quality, Regulatory, & HR', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,1.45,1.42,1.42,1.49,1.45,1.42,1.42,1.49,0.0,1.165283,-35.5,3358,3358,7296,5770,5770,1.4,1.54,900,3200,15063786,0.91,2.5,1.2339274,1.491,1.3361,0.0,0.0,USD,11685603,-0.40039003,5655153,10484900,37420,23763,1690761600,1693440000,0.0036000002,0.11525,0.40390998,4.48,0.0057,0.825,1.7212121,1672444800,1703980800,1688083200,-2855000,-0.26,-0.04,1:9,1562716800,0.957,-4.764,NCM,EQUITY,NEPH,NEPH,"Nephros, Inc.","Nephros, Inc.",1095773400,America/New_York,EDT,-14400000,1.42,2.5,buy,4060000,0.387,-2453000,857000,4.708,6.612,12208000,9.902,1.184,-0.13393,-0.25625,4731000,1873125,137000,0.244,0.53023,-0.20093,-0.2224,USD,
4,380 Lackawanna Place,South Orange,NJ,07079,United States,201-343-5202,https://www.nephros.com,Medical Instruments & Supplies,Healthcare,"Nephros, Inc. engages in development and sale of high performance water solutions to the medical and commercial markets in the United States. The company operates in two segments: Water Filtration and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it manufactures and sells water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and Nanoguard brands for the food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.",27,"{'maxAge': 1, 'name': 'Mr. Daron G. Evans', 'age': 48, 'title': 'Chief Exec. Officer of Specialty Renal Products, Inc', 'yearBorn': 1974, 'fiscalYear': 2020, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,1.45,1.42,1.42,1.49,1.45,1.42,1.42,1.49,0.0,1.165283,-35.5,3358,3358,7296,5770,5770,1.4,1.54,900,3200,15063786,0.91,2.5,1.2339274,1.491,1.3361,0.0,0.0,USD,11685603,-0.40039003,5655153,10484900,37420,23763,1690761600,1693440000,0.0036000002,0.11525,0.40390998,4.48,0.0057,0.825,1.7212121,1672444800,1703980800,1688083200,-2855000,-0.26,-0.04,1:9,1562716800,0.957,-4.764,NCM,EQUITY,NEPH,NEPH,"Nephros, Inc.","Nephros, Inc.",1095773400,America/New_York,EDT,-14400000,1.42,2.5,buy,4060000,0.387,-2453000,857000,4.708,6.612,12208000,9.902,1.184,-0.13393,-0.25625,4731000,1873125,137000,0.244,0.53023,-0.20093,-0.2224,USD,
5,380 Lackawanna Place,South Orange,NJ,07079,United States,201-343-5202,https://www.nephros.com,Medical Instruments & Supplies,Healthcare,"Nephros, Inc. engages in development and sale of high performance water solutions to the medical and commercial markets in the United States. The company operates in two segments: Water Filtration and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it manufactures and sells water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and Nanoguard brands for the food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.",27,"{'maxAge': 1, 'name': 'Mr. Greg  Lucas', 'title': 'Pres of Aether Water Systems', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,1.45,1.42,1.42,1.49,1.45,1.42,1.42,1.49,0.0,1.165283,-35.5,3358,3358,7296,5770,5770,1.4,1.54,900,3200,15063786,0.91,2.5,1.2339274,1.491,1.3361,0.0,0.0,USD,11685603,-0.40039003,5655153,10484900,37420,23763,1690761600,1693440000,0.0036000002,0.11525,0.40390998,4.48,0.0057,0.825,1.7212121,1672444800,1703980800,1688083200,-2855000,-0.26,-0.04,1:9,1562716800,0.957,-4.764,NCM,EQUITY,NEPH,NEPH,"Nephros, Inc.","Nephros, Inc.",1095773400,America/New_York,EDT,-14400000,1.42,2.5,buy,4060000,0.387,-2453000,857000,4.708,6.612,12208000,9.902,1.184,-0.13393,-0.25625,4731000,1873125,137000,0.244,0.53023,-0.20093,-0.2224,USD,
6,380 Lackawanna Place,South Orange,NJ,07079,United States,201-343-5202,https://www.nephros.com,Medical Instruments & Supplies,Healthcare,"Nephros, Inc. engages in development and sale of high performance water solutions to the medical and commercial markets in the United States. The company operates in two segments: Water Filtration and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it manufactures and sells water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and Nanoguard brands for the food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.",27,"{'maxAge': 1, 'name': 'Ms. Judy  Mazzini', 'title': 'Controller', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,1.45,1.42,1.42,1.49,1.45,1.42,1.42,1.49,0.0,1.165283,-35.5,3358,3358,7296,5770,5770,1.4,1.54,900,3200,15063786,0.91,2.5,1.2339274,1.491,1.3361,0.0,0.0,USD,11685603,-0.40039003,5655153,10484900,37420,23763,1690761600,1693440000,0.0036000002,0.11525,0.40390998,4.48,0.0057,0.825,1.7212121,1672444800,1703980800,1688083200,-2855000,-0.26,-0.04,1:9,1562716800,0.957,-4.764,NCM,EQUITY,NEPH,NEPH,"Nephros, Inc.","Nephros, Inc.",1095773400,America/New_York,EDT,-14400000,1.42,2.5,buy,4060000,0.387,-2453000,857000,4.708,6.612,12208000,9.902,1.184,-0.13393,-0.25625,4731000,1873125,137000,0.244,0.53023,-0.20093,-0.2224,USD,
